Exploring the molecular mechanisms regulating the interconnection between DNA demethylation and HDAC inhibition is important, since the combination of drugs targeting both acetylation and methylation can synergistically reduce cancer survival, as for example they may reactivate oncosuppressors such as the phosphatase and tensin homologue (PTEN) [16]. The gene discussed is HDAC9; the disease is cancer.